577541-U

BIOshell A160 Peptide Phenyl-Hexyl (2.7 μm) HPLC Columns

L × I.D. 0.5 cm × 2.1 mm, HPLC Guard Cartridge, pack of 3 ea

• Synonym(s): BIOshell A160 Peptide Phenyl-Hexyl, 2.7 μm HPLC Column
• UNSPSC Code: 41115700
• NACRES: SB.52

Properties

• Product Name: BIOshell A160 Peptide Phenyl-Hexyl, 2.7 μm HPLC Guard Cartridge, pack of 3 ea, cartridge L × I.D. 0.5 cm × 2.1 mm
• material: stainless steel column
• Agency: suitable for USP L11
• product line: BIOshell
• feature: endcapped
• packaging: pack of 3 ea
• extent of labeling: 4.7% Carbon loading
• technique(s): HPLC: suitable; LC/MS: suitable; UHPLC-MS: suitable; UHPLC: suitable
• cartridge L × I.D.: 0.5 cm × 2.1 mm
• surface area: 90 m²/g
• matrix: Fused-Core^® particle platform; superficially porous particle
• matrix active group: Phenyl-Hexyl (dimethylphenyl-hexylsilane) bonding phase
• particle size: 2.7 μm
• pore size: 160 Å pore size
• operating pH range: 2-9
• separation technique: reversed phase

Description

General description

BIOshell A160 Peptide Phenyl-Hexyl is a high-speed, high-performance liquid chromatography column based on a 160 Å Fused-Core^® particle design. The particle provides a thin porous shell of high-purity silica surrounding a solid silica core. This particle design exhibits very high column efficiency for high molecular weight solutes (up to 20 kDa) due to the shallow diffusion paths in the 0.5 μm thick porous shell and the small overall particle size of 2.7 μm. The end-capped, phenyl-hexyl bonded phase of the Peptide Phenyl-Hexyl provides a stable, reversed phase packing with a pore structure and pore size that is optimized for reversed-phase HPLC separations of peptides and polypeptides, using typical acidic mobile phases favored for proteomic applications.

Application

UHPLC Analysis of Peptides on BIOshell A160 Peptide C18, CN, and Phenyl-Hexyl, 2.7 μm

Analysis Note

The target analytes include peptides and polypeptides < 20 kDa.

Legal Information

Fused-Core is a registered trademark of Advanced Materials Technology, Inc.